NEWS
Norman, OK — The University of Oklahoma’s Gallogly College of Engineering is launching specialized workshops at the OU Bioprocessing Core Facility (OU BPCF), beginning Spring 2026. These workshops are designed to provide hands-on, equipment-specific training for both students and industry professionals, advancing workforce development and innovation in Oklahoma’s growing biomanufacturing and biotechnology sectors.
The initiative expands upon the OU Bioprocessing Certificate Program, a key component of the $35 million EDA grant-driven effort to strengthen workforce development and the state’s biotech ecosystem. Participants will gain practical experience using state-of-the-art bioprocessing equipment, preparing them to meet the demands of a rapidly evolving industry.
“These workshops are more than training sessions—they are an investment in Oklahoma’s future,” said John Klier, Dean of the Gallogly College of Engineering. “By equipping the workforce with advanced bioprocessing skills, we are fueling innovation, supporting industry growth, and positioning our state as a national leader in biotechnology.”
The OU Bioprocessing Core Facility serves as a regional and national resource for research, education, and industry collaboration, reinforcing OU’s commitment to driving discovery and translating innovation into real-world impact. Innovation thrives when knowledge meets application.
For more information about the OU Bioprocessing Core Facility workshops and registration details, visit the OU Bioprocessing Core Facility or contact us at bioprocessing@ou.edu
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.
The National Weather Service has, for the first time, purchased vertical atmospheric profiles collected by drones — data collected by the University of Oklahoma (OU) and Meteomatics. The milestone is the next step forward for the Oklahoma 3D Mesonet.
A University of Oklahoma researcher is part of an international team developing a new way to discover obesity drugs using human cells instead of animal models, an approach that could speed the development of more effective and affordable treatments. The effort is supported by a $12 million grant from the Novo Nordisk Foundation.
New findings from the University of Oklahoma, published in Cell Death & Disease, reveal that photoreceptors perform much of their own internal housekeeping.
